LEADER 06469nam 22005655 450 001 9910254544303321 005 20200707023039.0 010 $a3-319-26012-X 024 7 $a10.1007/978-3-319-26012-9 035 $a(CKB)3710000000657949 035 $a(EBL)4526231 035 $a(DE-He213)978-3-319-26012-9 035 $a(MiAaPQ)EBC4526231 035 $a(PPN)19407854X 035 $a(EXLCZ)993710000000657949 100 $a20160509d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBreast Disease$b[electronic resource] $eManagement and Therapies /$fedited by Adnan Aydiner, Abdullah ?gci, Atilla Soran 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (922 p.) 300 $aDescription based upon print version of record. 311 $a3-319-26010-3 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aSection I Invasive Breast Cancer Biopsy Techniques in non-Palpable or Palpable Breast Lesions -- Evaluation of Patients for Metastases Prior To Primary Therapy -- Staging of Breast Cancer -- Surgical Treatment of Early-Stage Breast Cancer -- Evaluation of Axillary Nodes -- Breast Reconstruction -- Adjuvant Systemic Therapy: Endocrine Therapy -- Adjuvant Systemic Chemotherapy for HER2-Negative Disease -- Adjuvant Therapy for Her-2/neu positive Early Breast Cancer -- Post-Mastectomy Adjuvant Radiotherapy (PMRT) -- Adjuvant Radiation Therapy after Preoperative Chemotherapy -- Breast-Conserving Therapy: Hypofractionated and Conventional Whole-Breast Irradiation and Accelerated Partial-Breast Irradiation -- Section II Preoperative systemic therapy Preoperative Therapy for Operable Breast Cancer -- Neoadjuvant Hormonal Therapy in Breast Cancer -- Systemic Therapy for Locally Advanced Breast Cancer -- Systemic Therapy for Inflammatory Breast Cancer --